Clinical Trials Browser

INDUSTRY × Carcinoma, Hepatocellular × Dietary Supplements × Clear all

NCT00502086 2011-02-11

Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection.

Phase 3 Completed

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic